Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Local epinephrine versus norepinephrine versus saline during coronary artery bypass graft surgery
IRCT20200603047645N1Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Dec 2019
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of epinephrine and norepinephrine in coronary arteriosclerosis (3 arms), sponsored by Arak University of Medical Sciences. Primary endpoints: Bleeding rate, Hemoglobin level and 1 more. Started Dec 2019; status: completed.
02
Drugs
epinephrinenorepinephrine
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on IRCT20200603047645N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200603047645N1.